Acromegaly is a systemic disease associated with increased morbidity, presenting
cardiovascular, metabolic, respiratory, neoplastic, endocrine, articular and bone …

Acromegaly is characterized by Growth Hormone (GH) and Insulin-like Growth Factor 1 (IGF-
1) excess. Uncontrolled acromegaly is associated with a strongly increased risk of …

Patients with acromegaly frequently develop cardiovascular comorbidities, which
significantly affect their morbidity and contribute to an increased all-cause mortality. In this …

Objective To assess differences in body image concerns among women with and without
polycystic ovary syndrome (PCOS). Design This is a systematic review and meta-analysis …

Introduction Symptomatic heart disease may be present in patients with advanced-stage
acromegaly. However, earlier assessment of subclinical ventricular systolic dysfunction can …

Aims Describe the local characteristics, methodology and results of the registry of
acromegalic patients in Colombia (RAPACO). Methods Multicenter, retrospective study …

Acromegaly is a rare and insidious disease characterized by chronic excess growth
hormone, leading to various morphological changes and systemic complications. Despite its …

Abstract Background Prader-Willi syndrome (PWS) is a rare complex genetic disorder and is
characterized by short stature, muscular hypotonia, abnormal body composition …

Acromegaly is a rare condition with an approximate incidence of 3-11 new cases per million
of population per year and a prevalence of approximately 60 per million (1). There are …

Background/Objectives: Acromegaly-induced prolonged exposure to growth hormone and
insulin-like growth factor 1 may have significant cardiovascular effects. The purpose of this …